2023³â Á¦35Â÷ °¡À» Çмú´ëȸ Çмú»ó ¹× Á¤Ã¥¿¬±¸ºñ, ¼¼Æ÷º´¸® Àǻ米À° ¼ºÀû ¿ì¼öÀÚ»ó ¼ö»óÀÚ ¸í´ÜÀ» ¾È³»ÇÏ¿© µå¸³´Ï´Ù .
ȸ¿ø ¿©·¯ºÐÀÇ ¸¹Àº ÃàÇÏ ºÎʵ右´Ï´Ù.
Á¦35Â÷ °¡À» Çмú´ëȸ ½Ã»ó½Ä ÀÏÁ¤
¢Ã ÀϽà : 2023 ³â 9¿ù 1ÀÏ(±Ý) 16:10 ~ 16:40 ÃÑȸ
¢Ã Àå¼Ò : ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ
Áø½ÉÀ¸·Î ÃàÇϵ帳´Ï´Ù!
Ç׸ñ
|
¼º¸í
|
¼Ò¼Ó
|
ºñ°í
|
25
ȸ Çмú´ë»ó
|
Á¤¿ä¼Á
|
°¡Å縯´ëÇб³ ÀÇÁ¤ºÎ¼º¸ðº´¿ø º´¸®°ú
|
Á¦¸ñ: Recent Application of Artificial Intelligence in
Non-Gynecological Cancer Cytopathology: A Systematic Review
°ÔÀçÁö: Cancers 2022
|
25
ȸ Çмú¿ì¼ö»ó
|
À¯ÇѼ®
|
¼¿ï´ëÇб³º´¿ø º´¸®°ú
|
Á¦¸ñ: Biomarkers expression among paired serous ovarian cancer primary
lesions and their peritoneal cavity metastases in treatment-naïve patients: A
single-center study
°ÔÀçÁö: Cancer Medicine 2022
|
¹ÚÁö¿µ(B)
|
°æºÏ´ëÇб³º´¿ø º´¸®°ú
|
Á¦¸ñ: Strategic significance of low viral load of human papillomavirus
in uterine cervical cytology specimens
°ÔÀçÁö: Diagnostics 2022
|
25
ȸ Çмú Àå·Á»ó
(JPTM ¼¼Æ÷³í¹® ÃÖ´Ù °ÔÀç»ó)
|
À¯ÇѼ®
|
¼¿ï´ëÇб³º´¿ø º´¸®°ú
|
¡¡
|
Á¤Ã¥¿¬±¸ºñ
|
±èÇöÁ¤
|
ÀÎÁ¦´ëÇб³ »ó°è¹éº´¿ø º´¸®°ú
|
ÀÎÀ¯µÎ¹ÙÀÌ·¯½º
ºñ ÀÇÁ¸¼º ÀڱðæºÎ »óÇÇ ³» ÀÌÇü¼ºÁõ ¹× ¾Ï¿¡¼ Àڱü¼Æ÷Áø °Ë»ç Áø´ÜÁ߿䵵 Àü±¹Á¶»ç
|
¼¼Æ÷º´¸® Àǻ米À° ¼ºÀû ¿ì¼öÀÚ»ó
|
±è¼öÈ
|
¼¿ï¼º¸ðº´¿ø º´¸®°ú
|
¡¡
|
¾çÇöÅÂ
|
°æºÏ´ëÇб³º´¿ø º´¸®°ú
|
¡¡
|
¿ÀÁöÀº
|
°í½Å´ëÇб³º¹À½º´¿ø º´¸®°ú
|
¡¡
|
Á¤¿íÀç
|
°æ»ó´ëÇб³º´¿ø º´¸®°ú
|
¡¡
|
|